Valsartan Intensified Primary Care Reduction of Blood Pressure Study

NCT00902304 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2337

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Valsartan and hydrochlorothiazide (HCTZ) - monotherapy
DRUG: Valsartan and amlodipine
DRUG: Usual care
DRUG: Valsartan
DRUG: Valsartan and hydrochlorothiazide (HCTZ) - combination arm

Sponsor

Novartis Pharmaceuticals

Collaborators

[object Object]